KTC
NPSP

Kistler-Tiffany Companies’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Kistler-Tiffany Companies’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2
Closed – – 751
2014
Q2 		$0 Buy
+2
New +$58 ﹤0.01% 713

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kistler-Tiffany Companies's NPSP Position: Q3 2014 in Review

Kistler-Tiffany Companies sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2014, closing a stake of 2 shares.

Kistler-Tiffany Companies first reported a position in NPSP in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • Kistler-Tiffany Companies reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 2 NPS PHARMACEUTICALS INC shares in Q3 2014.
  • Kistler-Tiffany Companies first reported a position in NPS PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Kistler-Tiffany Companies's NPS PHARMACEUTICALS INC position peaked at $0 in Q2 2014.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2014, filed 9 Oct 2014.